Prospective Study of Novel Peripheral Intravenous Catheter System With Nitinol Guidewire Compared to Published Literature for Conventional Intravenous Catheters

2015 ◽  
Vol 20 (4) ◽  
pp. 251
Author(s):  
Norman Anderson
Keyword(s):  
Prospective Study ◽  
Intravenous Catheter ◽  
Catheter System ◽  
Peripheral Intravenous Catheter ◽  
Intravenous Catheters

The AccuCath Intravenous Catheter System With Retractable Coiled Tip Guidewire and Conventional Peripheral Intravenous Catheters: A Prospective, Randomized, Controlled Comparison

2014 ◽  
Vol 19 (2) ◽  
pp. 94-102 ◽  
Author(s):  
Bette K. Idemoto ◽  
James R. Rowbottom ◽  
James D. Reynolds ◽  
Ronald L. Hickman
Keyword(s):  
Patient Satisfaction ◽  
User Satisfaction ◽  
Dwell Time ◽  
Adult Patients ◽  
Background Current ◽  
Intravenous Catheter ◽  
Randomized Controlled ◽  
Catheter System ◽  
Peripheral Intravenous Catheter ◽  
Intravenous Catheters

Abstract Background: Current peripheral intravenous catheter (PIV) first attempt success averages 47%, complications 47%, and dwell time 44 hours. Multiple intravenous (IV) access lines requiring replacement during each admission result in poor satisfaction and unnecessary costs. With 2011 Infusion Nursing Society standards allowing IV lines to dwell until complication, there is incentive to explore improvement opportunities. Purpose: A new, proprietary coiled tip guidewire PIV was compared with conventional IV catheters in adult patients. The experimental IV catheter was projected to have a higher rate of successful placement on first attempt, fewer complications, longer dwell times, higher completion of therapy, higher user satisfaction, and lower overall costs than conventional catheters. Methods: Adult patients requiring nonemergent IV catheters provided consent and were enrolled and randomized. The study, conducted over 4 months, included 248 patients (experimental IV group n =123, conventional IV group n =125). Results: Experimental IV first attempt success was 89% compared with 47% for the conventional catheter. Fifty percent of conventional IV placements required a second attempt. Experimental IV complications occurred 8% of the time and complications occurred with the conventional catheter 52% of the time. Completion of therapy was 89% with the experimental IV versus 34% with the conventional IV (P < .001). Dwell time improved with the experimental IV (mean 4.4 days [105 hours] vs conventional IV at 1.5 days [35 hours]) (P < .001). Overall patient satisfaction using a 5-point Likert scale scored an average of 4.5 with the experimental IV compared with the conventional IV, which scored 3. Conclusions: A new, proprietary coiled tip guidewire-delivered PIV demonstrated clear superiority over the conventional catheter in our study. Clinical outcome results showed statistically significant improvements in first attempt success, complications, completion of therapy, dwell time, and overall patient satisfaction.

Lifespan of peripheral intravenous short catheters in hospitalized children: A prospective study

2021 ◽  
pp. 112972982110052
Author(s):  
Maria Elizabeth Gómez-Neva ◽  
Martin Alonso Rondon Sepulveda ◽  
Adriana Buitrago-Lopez
Keyword(s):  
Cohort Study ◽  
Prospective Study ◽  
The Other ◽  
Hospitalized Children ◽  
Intravenous Catheter ◽  
Survival Analyses ◽  
Median Lifespan ◽  
Pediatric Services ◽  
A Prospective Study ◽  
Intravenous Catheters

Objective: To estimate the recommended lifespan of 223 peripheral intravenous accesses in pediatric services. Method: In this cohort study, we monitored the time of intravenous catheter between insertion and removal in children aged up to 15 years old in a Hospital from Bogotá-Colombia. The routine catheter observations was registered in questionnaires during nursing shifts. Survival analyses were performed to analyze the lifespan of the catheter free of complications. Results: The median lifespan of peripheral intravenous catheters without complications was 129 h (IQR 73.6–393.4 h). This median time free from complications was much lower for children ⩽1 year 98.3 h (IQR 63–141 h), than for participants aged >1 year 207.4 h (IQR 100–393 h). Catheters of 24 G (gauge) caliber had a median complication free time of 128 h (IQR 69–207 h) and 22 G calibers 144 h (IQR 103–393 h). Conclusions: In this study, 75% of peripheral indwell catheters remained free from complications for 74 h, the other extreme 25% of these patients could remain up to 393 h.

scholarly journals Peripheral Intravenous Catheter Placement Is an Underrecognized Source of Staphylococcus aureus Bloodstream Infection

2016 ◽  
Vol 3 (2) ◽  
Author(s):  
Eloise D. Austin ◽  
Sean B. Sullivan ◽  
Susan Whittier ◽  
Franklin D. Lowy ◽  
Anne-Catrin Uhlemann
Keyword(s):  
Staphylococcus Aureus ◽  
Bloodstream Infection ◽  
Catheter Placement ◽  
Intravenous Catheter ◽  
Staphylococcus Aureus Bacteremia ◽  
Peripheral Intravenous Catheter ◽  
Life Threatening ◽  
Staphylococcus Aureus Bloodstream Infection ◽  
Life Threatening Complication ◽  
Intravenous Catheters

Abstract Few studies have focused on the risks of peripheral intravenous catheters (PIVs) as sources for Staphylococcus aureus bacteremia (SAB), a life-threatening complication. We identified 34 PIV-related infections (7.6%) in a cohort of 445 patients with SAB. Peripheral intravenous catheter-related SAB was associated with significantly longer bacteremia duration and thrombophlebitis at old PIV sites rather than current PIVs.

scholarly journals Routine Replacement versus Clinical Monitoring of Peripheral Intravenous Catheters in a Regional Hospital in the Home Program A Randomized Controlled Trial

2009 ◽  
Vol 30 (9) ◽  
pp. 915-917 ◽  
Author(s):  
Patricia Van Donk ◽  
Claire M. Rickard ◽  
Matthew R. McGrail ◽  
Glenn Doolan
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Bloodstream Infections ◽  
Clinical Indication ◽  
Intravenous Catheter ◽  
Home Setting ◽  
Home Program ◽  
Randomized Controlled ◽  
Peripheral Intravenous Catheter ◽  
Intravenous Catheters

This randomized, controlled trial involving 316 patients in the home setting found no difference in the rate of phlebitis and/or occlusion among patients for whom a peripheral intravenous catheter was routinely resited at 72-96 hours and those for whom it was replaced only on clinical indication (76.8 events per 1,000 device-days vs 87.3 events per 1,000 device-days; P = .71). There were no bloodstream infections.

Unfavorable Peripheral Intravenous Catheter Replacements can be Reduced Using an Integrated Closed Intravenous Catheter System

2014 ◽  
Vol 15 (4) ◽  
pp. 257-263 ◽  
Author(s):  
Naoaki Tamura ◽  
Shizuko Abe ◽  
Kazue Hagimoto ◽  
Akemi Kondo ◽  
Ayako Matsuo ◽  
...  
Keyword(s):  
Intravenous Catheter ◽  
Catheter System ◽  
Peripheral Intravenous Catheter

scholarly journals Blood Culture Collection through Peripheral Intravenous Catheters Increases the Risk of Specimen Contamination among Adult Emergency Department Patients

2012 ◽  
Vol 33 (5) ◽  
pp. 524-526 ◽  
Author(s):  
Wesley H. Self ◽  
Theodore Speroff ◽  
Candace D. McNaughton ◽  
Patty W. Wright ◽  
Geraldine Miller ◽  
...  
Keyword(s):  
Emergency Department ◽  
Relative Risk ◽  
Blood Culture ◽  
Confidence Interval ◽  
Culture Collection ◽  
Blood Cultures ◽  
Intravenous Catheter ◽  
Peripheral Intravenous Catheter ◽  
Emergency Department Patients ◽  
Intravenous Catheters

Five hundred five blood cultures collected through a peripheral intravenous catheter (PIV) in an emergency department were matched to cultures obtained by dedicated venipuncture from the same patient within 10 minutes. The relative risk of contamination for cultures collected through PIVs compared with dedicated venipuncture was 1.83 (95% confidence interval, 1.08–3.11).

scholarly journals Risk Factors for Phlebitis in Patients with Peripheral Intravenous Catheters

2019 ◽  
Vol 12 (1) ◽  
pp. 41
Author(s):  
Fengmei Tan ◽  
Silin Zheng ◽  
Hongyan Wu ◽  
Lixia Nie ◽  
Wenhua Li ◽  
...  
Keyword(s):  
Risk Factors ◽  
Dwell Time ◽  
Insertion Site ◽  
Outer Diameter ◽  
Hypertonic Solution ◽  
Intravenous Catheter ◽  
Infusion Solution ◽  
Peripheral Intravenous Catheter ◽  
Insertion Sites ◽  
Intravenous Catheters

Introduction: The study investigated the risk factors of phlebitis associated with infusion by peripheral intravenous catheter (PIVC). Methodology: Hospitalized adults (n = 506) were placed with PIVCs by trained nurses. Rates of phlebitis were noted according to PIVC gauge, insertion site, and dwell time; and type and volume of infusion solution. Results: The development of phlebitis appeared to be significantly associated with the size of the outer diameter of the PIVC. The rate of phlebitis among patients given a hypertonic infusion solution was significantly higher; and also associated with infusion volume. There was no difference in phlebitis development among insertion sites, and dwell times among these sites were comparable. Conclusion: The risk of phlebitis increased with the PIVC size and volume of infusion solution, and use of a hypertonic solution. The recognition of risk factors and standardized intervention may reduce the occurrence of phlebitis associated with PIVC use.

The incidence and risk of infusion phlebitis with peripheral intravenous catheters: A meta-analysis

2019 ◽  
Vol 21 (3) ◽  
pp. 342-349 ◽  
Author(s):  
Luyu Lv ◽  
Jiaqian Zhang
Keyword(s):  
Risk Factors ◽  
Confidence Interval ◽  
Odds Ratio ◽  
Meta Analysis ◽  
Female Gender ◽  
Incidence Rates ◽  
Intravenous Catheter ◽  
Peripheral Intravenous Catheter ◽  
Meta Analyses ◽  
Intravenous Catheters

Introduction: Phlebitis is a common complication associated with the use of peripheral intravenous catheters. The aim of this study was to estimate the incidence of phlebitis with peripheral intravenous catheter use and to identify risk factors for phlebitis development. Method: Literature survey was conducted in electronic databases (CINAHL, Embase, Google Scholar, Ovid, and PubMed), and studies were included if they used peripheral intravenous catheter for therapeutic or volumetric infusion and reported phlebitis incidence rates. Random effects meta-analyses were performed to obtain overall and subgroup phlebitis incidence rates and odds ratio between males and females in phlebitis incidence. Results: Thirty-five studies were included (20,697 catheters used for 15,791 patients; age 57.1 years (95% confidence interval: 55.0, 59.2); 53.9% males (95% confidence interval: 42.3, 65.5)). Incidence of phlebitis was 30.7 per 100 catheters (95% confidence interval: 27.2, 34.2). Incidence of severe phlebitis was 3.6% (95% confidence interval: 2.7%, 4.6%). Incidence of phlebitis was higher in non-intervened (30% (95% confidence interval: 27%, 33%)) than in intervened (21% (95% confidence interval: 15%, 27%)) groups, and with Teflon (33% (95% confidence interval: 25%, 41%)) than Vialon (27% (95% confidence interval: 21%, 32%)) cannula use. Odds of developing phlebitis was significantly higher in females (odds ratio = 1.42 (95% confidence interval: 1.05, 1.93); p = 0.02). Longer dwelling time, antibiotics infusion, female gender, forearm insertion, infectious disease, and Teflon catheter are important risk factors for phlebitis development identified by the included studies. Conclusion: Incidence of phlebitis with the use of peripheral intravenous catheters during infusion is 31%. Severe phlebitis develops in 4% of all patients. Risk of phlebitis development can be reduced by adapting appropriate interventions.

Sign in / Sign up

Export Citation Format

Share Document